TCS whitepaper

Reimagining the Clinical Trials Process through Digital Disruption

Conventional clinical trial processes require significant time and resources to be invested for data cleaning, monitoring, and reporting to the concerned regulatory authorities. This directly influences the cost of the trial, and thus the time to market. Explore how digitization of clinical trial processes can help transform the clinical research industry. The clinical trials industry manages large volumes of patient data …

Efficiency, Enhancing, Collaboration, Clinical, Trials, Clinical Innovation

Efficiency Enhancing Collaboration in Clinical Trials

At the 2014 Clinical Innovation Congress, Pete Milligan, TransCelerate Biopharma inc, gave a presentation on “Efficiency Enhancing Collaboration in Clinical Trials”. Download and learn: Collaboration Ongoing Initiatives Key Accomplishments to Date The future New Initiatives Download this presentation: Found this interesting? Join us at the 2nd annual Clinical Innovation Congress (formerly Disruptive Innovation in Clinical Trials).  The Congress will share insight …

Download: How adaptive trial design can improve efficacy and accuracy of results

  At last years BioPharma Asia Convention,  Dejun Tang, Director of Biometrics, China delivered the presentation: Implementing Adaptive Trial Design to Improve Efficacy and Accurate Results Collection His presentation includes: Adaptive Design Definition Discussions on Adaptive Design Definition Examples of Adaptive Designs Novartis Case Study Click here to download the presentation If you found this presentation interesting then you may …

Successfully managing the relationship between cold chain management and clinical trial operations by Mr Stanley Soh, World Courier

Speaking on the above topic is Mr Stanley Soh, Regional AQ Manager, Asia Pacific, World Courier, Singapore. He will be making a presentation at Pharma Trials World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012. Mr Stanley Soh is the Regional QA Manager for World Courier. He has nearly 2 decades of …

Whitepaper Download – Managing Clinical Trials and Central Laboratory Services in China, by PPD

China's huge population and growing commitment to health care are predicted to make the country the world's second-largest consumer of pharmaceuticals by 2015. However, despite the size of the market, the large numbers of treatment-naïve patients, and the necessity of collecting clinical trial data patients in China before the Chinese State Food and Drug Administration (SFDA) will approve a drug …

Clinical Trials Benefit From New-Generation LIMS

Presenting on the above topic is Chamnong Ingsathit, Consultant, Labware, Thailand. He will be speaking at 5th Annual BioPharma Asia Convention 2012, held on 19th to 22nd March 2012 at Marina Bay Sands, Singapore. He will be conducting an on-floor seminar at Theatre 1 at 11:00 on the 20th of March. Here is a short abstract on what he will …

White Paper Download – Clinical Trials Benefit From Advanced LIMS

In this White Paper, Robin Longdin of LCG Bioscience and Nick Townsend of LabWare Europe discuss the introduction of a new-generation laboratory information management system (LIMS) into a busy Phase I clinical trials facility. Laboratory information management systems (LIMS) are widely used to automate laboratory processing and to assist with regulatory compliance. Organisations that installed LIMS many years ago are …

Featured panelist: Dr Rikrik Ilyas, Innogene

Our featured panelist for this post is Dr Rikrik Ilyas, Managing Director, Innogene Kalbiotech, Singapore. She will be speaking at Pharma Trials World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012. Dr Rikrik Ilyas, MSc, PhD has over 25 years of experience in the field of R&D, Regulatory, Clinical Research, Business Development, …

Effectively managing preclinical studies input from global sites for your preclinical pipeline

Speaking on the above is Dr Jan Jiricek, Principal Scientist – Chemistry, Novartis Institute for Tropical Diseases, Singapore. He will be presenting at Pre-clinical World Asia 2012, part of the 5th Annual BioPharma Asia Convention 2012. Dr. Jiricek is currently working in the field of Tuberculosis-Drug-Discovery at the Novartis Institute for Tropical Diseases, Singapore. He received his Diploma in Chemistry …

Customizing your global regulatory strategy for efficient drug development, by Dr Joseph Scheeren, #Bayer Healthcare

Speaking on the above topic is Dr Joseph Scheeren, SVP & Head, Global Regulatory Affairs, Bayer Healthcare, United States. He will be making a presentation at Pre-clinical World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012. Dr Scheeren was born and raised in the Netherlands and studied pharmacy at the University of …